Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine whether an experimental drug known as tadalafil
can reduce symptoms of dyspepsia (fullness after eating, inability to finish a regular meal,
bloating, discomfort or pain in the upper abdomen, belching after meals, nausea, vomiting) in
diabetic patients, and/or reduce the amount of time the stomach takes to empty the contents
of a standard meal. The safety of tadalafil given once daily for 8 weeks in this population
will also be studied.